跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Novovast
Approved
STANDARD
Novovast
Lifesquare Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d6c56828f852c2c0
Company
Lifesquare Laboratories Inc.
Type
Standard
Approval Details
Approval Id
d6c56828f852c2c0
Drug Approval Philippines Name
Novovast
Product Name
Novovast
Registration Number
DRP-3685
Brand Name
Novovast
Generic Name
Simvastatin
Dosage Form
Tablet
Dosage Strength
20 mg
Manufacturer
Lifesquare Laboratories Inc.
Issuance Date
27 July 2023
Expiry Date
28 October 2028
Pharmacologic Category
HMG-CoA Reductase Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d6c56828f852c2c0
Type
Standard
Back to Philippines FDA Approvals
Novovast - Philippines FDA Drug Approval Details